Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema. Durrani AF, Momenaei B, Wakabayashi T, Vemula S, et al. Br J Ophthalmol 2024 Feb 12:bjo-2023-324394. doi: 10.1136/bjo-2023-324394.

Read + Share

Amedeo Smart

Independent Medical Education

Durrani AF, Momenaei B, Wakabayashi T, Vemula S, et al. Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema. Br J Ophthalmol 2024 Feb 12:bjo-2023-324394. doi: 10.1136/bjo-2023-324394.
PMID: 38346854